DTL
PHAT icon

Dynamic Technology Lab’s Phathom Pharmaceuticals PHAT Stock Holding History

Dynamic Technology Lab’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,111
Closed -$135K – 993
2026
Q1 		$135K Buy
+12,111
New +$153K 0.02% 781
2024
Q1 		– Sell
-15,000
Closed -$137K – 1334
2023
Q4 		$137K Buy
+15,000
New +$129K 0.01% 923

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Dynamic Technology Lab's PHAT Position: Q2 2026 in Review

Dynamic Technology Lab sold out of Phathom Pharmaceuticals (PHAT) in Q2 2026, closing a stake of 12,111 shares — an estimated $135K sold.

Dynamic Technology Lab first reported a position in PHAT in Q4 2023 and held it in 2 quarters. The position peaked at $137K in Q4 2023. 162 funds tracked by Wall St. Rank hold PHAT as of Q2 2026.

  • Dynamic Technology Lab reported no remaining Phathom Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Dynamic Technology Lab sold 12,111 Phathom Pharmaceuticals shares in Q2 2026, an estimated $135K.
  • Dynamic Technology Lab first reported a position in Phathom Pharmaceuticals in Q4 2023 and held it in 2 quarters.
  • Dynamic Technology Lab's Phathom Pharmaceuticals position peaked at $137K in Q4 2023.
  • 162 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q2 2026.

Based on Dynamic Technology Lab's 13F filing for Q2 2026, filed 13 Aug 2026.